158 results
8-K
CLRB
Cellectar Biosciences Inc
2 Nov 23
Reports Preliminary Financial Results for Third Quarter 2023 and Provides a Corporate Update
7:45am
2, 2023, entitled “Cellectar to Release Top-line Data from WM Pivotal Trial During the JP Morgan Healthcare Conference the Week of January 8, 2024
8-K
EX-99.1
CLRB
Cellectar Biosciences Inc
2 Nov 23
Reports Preliminary Financial Results for Third Quarter 2023 and Provides a Corporate Update
7:45am
Exhibit 99.1
Cellectar to Release Top-line Data from WM Pivotal Trial During the JP Morgan Healthcare Conference the Week of January 8, 2024 … in Waldenstrom’s macroglobulinemia (WM) will be released during the JP Morgan Healthcare conference the week of January 8, 2024.
Third Quarter and Recent
424B3
CLRB
Cellectar Biosciences Inc
30 Oct 23
Prospectus supplement
7:05pm
)
Blackwell Partners LLC - Series A (10)
Bigger Capital Fund, LP (11)
District 2 Capital Fund, LP (12)
AuGC BioFund LP (13)
Healthcare Opportuntities
8-K
EX-10.1
4fe4q
8 Sep 23
Entry into a Material Definitive Agreement
5:17pm
8-K
EX-99.1
daqsvo5sw
4 May 23
Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update
8:45am
8-K
EX-1.1
3ysueo w9g1wt
25 Oct 22
Entry into a Material Definitive Agreement
5:03pm
424B5
5amcbag 9nt7271
24 Oct 22
Prospectus supplement for primary offering
4:36pm
8-K
ifyy51
15 Mar 22
Results of Operations and Financial Condition
4:32pm
8-K
EX-99.1
vi6i6yz3 3fu
15 Mar 22
Results of Operations and Financial Condition
4:32pm
8-K
EX-99.1
dg2fp2gxyyt6337ic5
25 Feb 22
Cellectar Biosciences Announces Executive Leadership Changes
4:05pm
8-K
EX-99.1
1zssst71c
15 Sep 21
Cellectar to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
4:16pm
8-K
ouqq1frpj3 pkkz
15 Sep 21
Cellectar to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
4:16pm